Wells Fargo & Company Ardelyx, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Ardelyx, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 884,165 shares of ARDX stock, worth $5.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

884,165

Previous 116,579 658.43%

Holding current value

$5.61 Million

Previous $851,000 669.8%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.89 - $9.31 $4.52 Million - $7.15 Million	767,586 Added 658.43%	884,165 $6.55 Million
Q1 2024 May 10, 2024	BUY	$6.05 - $9.74 $62,375 - $100,419	10,310 Added 9.7%	116,579 $851,000
Q4 2023 Feb 09, 2024	SELL	$3.29 - $6.64 $589,127 - $1.19 Million	-179,066 Reduced 62.76%	106,269 $658,000
Q3 2023 Nov 13, 2023	SELL	$3.3 - $4.83 $597,890 - $875,094	-181,179 Reduced 38.84%	285,335 $1.16 Million
Q2 2023 Aug 15, 2023	BUY	$3.23 - $4.95 $581,664 - $891,405	180,082 Added 62.87%	466,514 $1.58 Million
Q1 2023 May 12, 2023	BUY	$2.68 - $4.79 $690,649 - $1.23 Million	257,705 Added 897.08%	286,432 $1.37 Million
Q4 2022 Feb 13, 2023	SELL	$1.22 - $2.85 $7,625 - $17,812	-6,250 Reduced 17.87%	28,727 $81,000
Q3 2022 Nov 14, 2022	SELL	$0.59 - $1.44 $1,969 - $4,806	-3,338 Reduced 8.71%	34,977 $41,000
Q2 2022 Aug 12, 2022	SELL	$0.51 - $1.17 $10,481 - $24,045	-20,552 Reduced 34.91%	38,315 $23,000
Q1 2022 May 16, 2022	SELL	$0.65 - $1.18 $22,570 - $40,974	-34,724 Reduced 37.1%	58,867 $63,000
Q4 2021 Feb 14, 2022	SELL	$0.86 - $1.7 $16,028 - $31,684	-18,638 Reduced 16.61%	93,591 $103,000
Q3 2021 Nov 15, 2021	BUY	$1.27 - $8.17 $138,071 - $888,226	108,718 Added 3096.5%	112,229 $148,000
Q2 2021 Aug 16, 2021	SELL	$6.55 - $8.98 $35,723 - $48,976	-5,454 Reduced 60.84%	3,511 $26,000
Q1 2021 May 13, 2021	SELL	$6.1 - $7.69 $466,570 - $588,185	-76,487 Reduced 89.51%	8,965 $59,000
Q4 2020 Feb 09, 2021	SELL	$5.05 - $7.1 $358,938 - $504,646	-71,077 Reduced 45.41%	85,452 $553,000
Q3 2020 Nov 05, 2020	BUY	$5.25 - $7.08 $9,597 - $12,942	1,828 Added 1.18%	156,529 $822,000
Q2 2020 Aug 13, 2020	BUY	$5.37 - $8.11 $605,102 - $913,851	112,682 Added 268.17%	154,701 $1.07 Million
Q1 2020 May 14, 2020	BUY	$4.35 - $8.79 $182,782 - $369,347	42,019 New	42,019 $239,000

Others Institutions Holding ARDX

# of Institutions

209

Shares Held

144M

Call Options Held

1.01M

Put Options Held

1.43M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $980M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Ardelyx, Inc. Transaction History